$30.90
$0.00 (0.00%)
End-of-day quote: 06/01/2024
NasdaqGS:IART

Integra LifeSciences Holdings Annual Report

Year Year 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004
Rev. Revenue
$1.54B $1.56B $1.54B $1.37B $1.52B $1.47B $1.19B $992.08M $882.73M $796.72M $696.83M $830.87M $780.08M $732.07M $682.49M $654.60M $550.46M $419.30M $277.94M $229.83M
GM % Gross Margin %
61.49% 63.05% 63.34% 64.55% 64.46% 63.53% 65.74% 66.71% 64.98% 64.12% 62.37% 64.13% 64.06% 64.11% 65.17% 62.72% 62.43% 61.03% 63.01% 61.61%
OM Operating Margin
16.87% 17.51% 18.07% 16.02% 17.20% 16.02% 15.20% 16.03% 15.49% 15.79% 11.55% 13.71% 14.67% 15.64% 15.65% 15.60% 14.48% 17.14% 22.91% 10.90%
EPS Earnings Per Share
$0.00 $3.10 $3.36 $3.18 $2.45 $2.74 $2.42 $1.94 $1.76 $1.54 $1.48 $1.23 $1.53 $1.40 $1.39 $1.08 $1.05 $0.80 $0.71 $0.65 $0.54
Div. Dividends
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
PR % Payout Ratio %
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0 0 0.00% 0.00% 0.00% 0
Sha. Shares
78.17m 83.65m 84.7m 84.34m 85.87m 85.16m 78.39m 74.72m 73.88m 65.47m 64.28m 55.9m 53.66m 57.07m 57.21m 56m 51.8m 54.63m 54.91m 56.97m
OCF Operating Cash Flow
$139.96M $264.47M $312.43M $203.83M $231.43M $199.68M $114.54M $116.41M $104.85M $83.57M $53.27M $59.10M $104.33M $105.57M $143.24M $72.59M $47.03M $71.70M $56.85M $38.98M
FCF Free Cash Flow
$116.40M $222.13M $264.41M $164.94M $161.90M $121.94M $71.04M $69.08M $61.07M $37.54M $5.42M $-10.32M $65.90M $68.43M $118.00M $59.19M $24.46M $60.18M $48.80M $30.47M
FCFS Free Cash Flow Per Share
$0.91 $2.62 $3.12 $1.65 $1.13 $1.47 $0.92 $0.93 $1.04 $0.69 $0.19 $-0.18 $1.14 $1.16 $1.99 $1.07 $0.44 $1.03 $0.81 $0.51